TrialBritish journal of cancer2014

Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial.

B Escudier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.